|Bid||37.50 x 900|
|Ask||37.94 x 1000|
|Day's Range||36.24 - 39.27|
|52 Week Range||35.73 - 71.91|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||55.80|
AbCellera will present at the 10th Annual SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 1:20 p.m. Pacific Time.
AbCellera announced today that Ester Falconer, Ph.D., has been appointed Chief Technology Officer, effective January 28, 2021.
Shares of IPO stock AbCellera Biologics returned gains Wednesday after its Eli Lilly-partnered Covid-19 treatment nabbed a Food and Drug Administration second emergency use authorization.